Tiziana Life Sciences income statement data for the quarter ended Dec 2025. This income statement covers 17 quarters of results from Dec 2017 through Dec 2025, standardized by Business Quant from the company’s SEC filings.
| Income Statement | Dec2017 | Jun2018 | Dec2018 | Jun2019 | Dec2019 | Jun2020 | Dec2020 | Jun2021 | Dec2021 | Jun2022 | Dec2022 | Jun2023 | Dec2023 | Jun2024 | Dec2024 | Jun2025 | Dec2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Shares Outstanding (Entity)Shares Outstanding (Entity.) | 125.05M | 136.46M | 136.65M | 194.61M | 102.27M | 102.27M | 103.09M | 111.46M | 120.51M | ||||||||
| Additional items | |||||||||||||||||
| Shares Outstanding | 106.40M | 106.40M | 127.55M | 127.55M | 136.48M | 136.48M | 169.07M | 169.07M | 97.93M | 97.93M | 101.53M | 101.53M | 102.47M | 102.47M | 106.67M | 106.67M | 118.28M |